Methyldopa can cause fluid retention and potentially alter electrolytes. Monitoring electrolyte levels and adjusting doses of concurrent antihypertensives can manage this risk.

Methyldopa may lead to electrolyte imbalances by promoting sodium and water retention. Regular blood tests and dose adjustments of other antihypertensive medications are recommended to manage these imbalances.

Yes, methyldopa can disrupt electrolyte balance by causing sodium retention. It’s important to monitor electrolytes regularly and adjust other antihypertensive drugs as needed to mitigate this issue.